EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer

Tomonori Oka, Sabrina S Smith, Valeria S Oliver-Garcia, Truelian Lee, Heehwa G Son, Mahsa Mortaja, Marjan Azin, Anna C Garza-Mayers, Jennifer T Huang, Rosalynn M Nazarian, Thomas D Horn, Shadmehr Demehri

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Tomonori Oka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Krantz Family Center for Cancer Research, Massachus…. Hauptthemen laut MEDLINE: Skin Neoplasms, Basal Cell Carcinoma, Mutation, Epigenomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, Burroughs Wellcome Fund, LEO Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsBasal Cell CarcinomaMutationEpigenomicsNeoplastic Stem CellsEpigenesis, GeneticHumansAnimalsMicePyridinesBenzamidesForkhead Transcription FactorsImmunotherapyImiquimodHistocompatibility Antigens Class ICarcinoma, Squamous CellCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CP: CancerFoxc1HLA-IIRF1antigen processing and presentation machinerybasal cell carcinomacutaneous squamous cell carcinomaentinostathair follicle stem cellimmunotherapy

Substanzen

entinostatPyridinesBenzamidesForkhead Transcription FactorsImiquimodHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Dermatology Section, Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Dep…

Förderung

  • NIAMS NIH HHS
  • Burroughs Wellcome Fund
  • LEO Foundation
  • Society for Pediatric Dermatology
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Oka, T., Smith, S. S., Oliver-Garcia, V. S., Lee, T., Son, H. G., Mortaja, M., Azin, M., Garza-Mayers, A. C., Huang, J. T., Nazarian, R. M., Horn, T. D., & Demehri, S. (2025). Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115561

Vancouver

Oka T, Smith SS, Oliver-Garcia VS, Lee T, Son HG, Mortaja M, et al. Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115561

BibTeX
@article{Oka2025,
  author = {Oka, Tomonori and Smith, Sabrina S and Oliver-Garcia, Valeria S and Lee, Truelian and Son, Heehwa G and Mortaja, Mahsa and Azin, Marjan and Garza-Mayers, Anna C and Huang, Jennifer T and Nazarian, Rosalynn M and Horn, Thomas D and Demehri, Shadmehr},
  title = {Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115561}
}
Kostenlos starten →